10-Q/APeriod: Q2 FY2005

AXON ENTERPRISE, INC. Quarterly Report (Amendment) for Q2 Ended Jun 30, 2005

Filed January 13, 2006For Securities:AXON

Summary

TASER International, Inc. (now Axon Enterprise, Inc.) filed an amended Form 10-Q for the quarter ended June 30, 2005, primarily to restate its financial statements due to errors in the accrual of legal and professional fees. The restatement shifted expenses between quarters, impacting net income but not revenue. Financially, the company saw a significant decline in net sales for the first six months of 2005 compared to the same period in 2004, attributed to negative publicity surrounding its products and increased legal/public relations expenses. Despite the sales decrease, the company maintained substantial cash and investment balances, with no debt outstanding as of June 30, 2005, and had availability under its credit line. The company is facing numerous lawsuits, including securities, shareholder derivative, contract, and product liability litigation, which pose ongoing risks and uncertainty.

Key Highlights

  • 1Financial statements for the quarter ended June 30, 2005, were restated due to accounting errors in legal and professional fees, impacting expense recognition but not revenue.
  • 2Net sales decreased by 21% for the first six months of 2005 compared to the same period in 2004, largely due to negative publicity and longer sales cycles.
  • 3Gross margin percentage declined in the first six months of 2005 due to increased cost of products sold per unit, driven by lower device sales volume and a shift in sales mix.
  • 4Sales, General & Administrative (SG&A) expenses nearly doubled in the first six months of 2005 compared to the prior year, primarily due to increased legal, public relations, and consulting costs.
  • 5The company had $46.1 million in Total Current Assets and $110.4 million in Total Assets as of June 30, 2005, with $8.2 million in Total Liabilities.
  • 6As of June 30, 2005, the company had $44.0 million in cash and investments and no debt outstanding, demonstrating a strong liquidity position.
  • 7TASER International is subject to multiple significant legal proceedings, including a consolidated securities class action lawsuit, shareholder derivative litigation, contract disputes, and numerous product liability lawsuits, creating substantial uncertainty.

Frequently Asked Questions

The financial statements were restated to correct errors in the accrual of legal and professional fees and other expenses. Invoices were not always received or recorded in the correct accounting period due to delays by third parties, leading to expenses being shifted between quarters.

The company reported a significant decrease in net sales for the first six months of 2005 compared to 2004. This decline is attributed to ongoing negative press coverage concerning the company's products and their use, which has led to longer sales cycles and delays in orders from potential customers.

As of June 30, 2005, TASER International had $46.1 million in current assets and $110.4 million in total assets, with total liabilities of $8.2 million. The company maintained a strong liquidity position with $44.0 million in cash and investments and no outstanding debt. They also had $5.8 million in availability under a $10 million revolving line of credit.

TASER International is involved in substantial litigation. This includes a consolidated securities class action lawsuit, shareholder derivative lawsuits alleging breach of fiduciary duties, contract disputes (including one seeking up to $400 million), and 35 product liability lawsuits related to alleged wrongful death or personal injury. The company also noted an ongoing informal inquiry from the SEC.